These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 17964975

  • 1. Ibuprofen does not affect levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptor types I and II in Gabonese children with uncomplicated Plasmodium falciparum malaria.
    Matsiegui PB, Missinou MA, Issifou S, Necek M, Mavoungou E.
    Eur Cytokine Netw; 2007 Dec; 18(4):201-5. PubMed ID: 17964975
    [Abstract] [Full Text] [Related]

  • 2. The role of soluble tumor necrosis factor receptor types I and II and tumor necrosis factor-alpha in malaria during pregnancy.
    Davison BB, Kaack MB, Rogers LB, Rasmussen KK, Rasmussen TA, Henson EW, Henson MC, Parekh FK, Krogstad DJ.
    J Infect Dis; 2006 Jul 01; 194(1):123-32. PubMed ID: 16741891
    [Abstract] [Full Text] [Related]

  • 3. Relationship between antipyretic effects and cytokine levels in uncomplicated falciparum malaria during different treatment regimes.
    Hugosson E, Montgomery SM, Premji Z, Troye-Blomberg M, Björkman A.
    Acta Trop; 2006 Aug 01; 99(1):75-82. PubMed ID: 16962547
    [Abstract] [Full Text] [Related]

  • 4. Distinct patterns of cytokine regulation in discrete clinical forms of Plasmodium falciparum malaria.
    Akanmori BD, Kurtzhals JA, Goka BQ, Adabayeri V, Ofori MF, Nkrumah FK, Behr C, Hviid L.
    Eur Cytokine Netw; 2000 Mar 01; 11(1):113-8. PubMed ID: 10705308
    [Abstract] [Full Text] [Related]

  • 5. [Serum levels of solubule tumor necrosis factor (TNF) receptors in patients with pulmonary tuberculosis].
    Kawaguchi H, Ina Y, Ito S, Sato S, Sugiura Y, Tomita H, Ogisu N, Takada K, Yamamoto M, Morishita M, Yoshikawa K.
    Kekkaku; 1996 Mar 01; 71(3):259-65. PubMed ID: 8901228
    [Abstract] [Full Text] [Related]

  • 6. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I, Dorsey G, Rouamba N, Dokomajilar C, Séré Y, Rosenthal PJ, Ouédraogo JB.
    Clin Infect Dis; 2007 Dec 01; 45(11):1453-61. PubMed ID: 17990228
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Short course of quinine plus a single dose of sulfadoxine/pyrimethamine for Plasmodium falciparum malaria.
    Matsiegui PB, Missinou MA, Necek M, Issifou S, Kremsner PG.
    Wien Klin Wochenschr; 2006 Oct 01; 118(19-20):610-4. PubMed ID: 17136336
    [Abstract] [Full Text] [Related]

  • 9. Diminished Plasmodium falciparum sensitivity to quinine exposure in vitro and in a sequential multi-drug regimen: A preliminary investigation in Guyana, South America.
    Best Plummer W, Pinto Pereira L.
    Int J Infect Dis; 2008 Nov 01; 12(6):e27-31. PubMed ID: 18573671
    [Abstract] [Full Text] [Related]

  • 10. Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria.
    Brandts CH, Ndjavé M, Graninger W, Kremsner PG.
    Lancet; 1997 Sep 06; 350(9079):704-9. PubMed ID: 9291905
    [Abstract] [Full Text] [Related]

  • 11. Severe malarial anemia associated with increased soluble Fas ligand (sFasL) concentrations in Gabonese children.
    Issifou S, Mavoungou E, Borrmann S, Bouyou-Akotet MK, Matsiegui PB, Kremsner PG, Ntoumi F.
    Eur Cytokine Netw; 2003 Sep 06; 14(4):238-41. PubMed ID: 14715416
    [Abstract] [Full Text] [Related]

  • 12. Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial.
    Macete E, Aide P, Aponte JJ, Sanz S, Mandomando I, Espasa M, Sigauque B, Dobaño C, Mabunda S, DgeDge M, Alonso P, Menendez C.
    J Infect Dis; 2006 Aug 01; 194(3):276-85. PubMed ID: 16826474
    [Abstract] [Full Text] [Related]

  • 13. Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia.
    Spinas GA, Keller U, Brockhaus M.
    J Clin Invest; 1992 Aug 01; 90(2):533-6. PubMed ID: 1322942
    [Abstract] [Full Text] [Related]

  • 14. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
    Marfurt J, Müeller I, Sie A, Maku P, Goroti M, Reeder JC, Beck HP, Genton B.
    Am J Trop Med Hyg; 2007 Nov 01; 77(5):947-54. PubMed ID: 17984359
    [Abstract] [Full Text] [Related]

  • 15. [The significance of detecting tumor necrosis factor-alpha and its receptors in serum and pleural effusion in differentiating tuberculosis and malignant pleural effusions].
    Zhou J, Zhao Q, Yao H.
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Mar 01; 23(3):158-60. PubMed ID: 11778489
    [Abstract] [Full Text] [Related]

  • 16. The effects of quinine and artesunate treatment on plasma tumor necrosis factor levels in malaria-infected patients.
    Ittarat W, Udomsangpetch R, Chotivanich KT, Looareesuwan S.
    Southeast Asian J Trop Med Public Health; 1999 Mar 01; 30(1):7-10. PubMed ID: 10695778
    [Abstract] [Full Text] [Related]

  • 17. Treatment of quinine resistant falciparum malaria in Thai children.
    Chongsuphajaisiddhi T, Sabchareon A, Attanath P.
    Southeast Asian J Trop Med Public Health; 1983 Sep 01; 14(3):357-62. PubMed ID: 6362017
    [Abstract] [Full Text] [Related]

  • 18. Molecular markers of resistance to sulfadoxine-pyrimethamine during intermittent preventive treatment for malaria in Mozambican infants.
    Mayor A, Serra-Casas E, Sanz S, Aponte JJ, Macete E, Mandomando I, Puyol L, Berzosa P, Dobaño C, Aide P, Sacarlal J, Benito A, Alonso P, Menéndez C.
    J Infect Dis; 2008 Jun 15; 197(12):1737-42. PubMed ID: 18419347
    [Abstract] [Full Text] [Related]

  • 19. High serum TNF-alpha level in Type 2 diabetic patients with microangiopathy is associated with eNOS down-regulation and apoptosis in endothelial cells.
    Makino N, Maeda T, Sugano M, Satoh S, Watanabe R, Abe N.
    J Diabetes Complications; 2005 Jun 15; 19(6):347-55. PubMed ID: 16260352
    [Abstract] [Full Text] [Related]

  • 20. Relationship between circulating tumor necrosis factor system and bone mass before and after estrogen plus progestogen therapy.
    Kim JG, Ku SY, Kim H, Chun SW, Suh CS, Choi YM.
    Menopause; 2009 Jun 15; 16(3):534-8. PubMed ID: 19225428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.